Book a demo

Company intelligence

Hugel Aesthetics

Pharmaceutical Manufacturing
Irvine, US
224 employees
3 public signals

About Hugel Aesthetics

Founded in 2001, Hugel is a South Korea–based global leader in medical aesthetics, specializing in the development and commercialization of botulinum toxin, hyaluronic acid fillers, skin boosters, threads, and biocosmetics. Over the past two decades, Hugel has built a strong global footprint, with commercial presence in approximately 70 countries and operations across nine international subsidiaries. Leveraging strong global momentum, Hugel Aesthetics was formed as the Company’s dedicated North American business unit, established to lead commercialization in the United States, Canada and Australia. Backed by Hugel’s global scale and expertise, Hugel Aesthetics is a well-resourced, growth-oriented organization focused on expanding access to its flagship neurotoxin and establishing a strong, long-term presence in medical aesthetics.

Verified activity

Signals from Hugel Aesthetics

3 published signals

Find the companies already in motion.

Customize signals around your market, buyers, competitors, and investment thesis.

© 2026 SeedOpsCompany intelligence.

SeedOps.

Hugel Aesthetics Company Signals | SeedOps